Earnings NewsHealthcareSeres Therapeutics GAAP EPS of -$0.72 misses by $0.10, revenue of $144.92M misses by $4.9MMar. 01, 2022 7:13 AM ETSeres Therapeutics, Inc. (MCRB)By: Deepa Sarvaiya, SA News Editor Seres Therapeutics press release (NASDAQ:MCRB): FY GAAP EPS of -$0.72 misses by $0.10. Revenue of $144.92M (+334.8% Y/Y) misses by $4.9M. Recommended For YouCommentsNewestPublishHave a tip? Submit confidentially to our News team. Found a factual error? Report here.More Trending NewsNasdaq, S&P, Dow fall as Wall Steet takes a breather after notching 2023 closing highU.S. strong buy ideas for the next 12 months – according to CitiTech to rally in 2024 as AI leads biggest transformation since birth of the internet: WedbushFranklin Templeton CEO Jenny Johnson holds bitcoin, ether, other cryptos - reportTop 10 trades for 2024 - BofASee More »About MCRBSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Short InterestPrev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgMCRB--Seres Therapeutics, Inc.ATNM--Actinium Pharmaceuticals, Inc.PRQR--ProQR Therapeutics N.V.DSGN--Design Therapeutics, Inc.IMAB--I-MabCompareTrending AnalysisTrending News